July 8, 2009 - Covidien said today Health Canada approved the company’s abbreviated new drug submission (ANDS) for its kit for the preparation of technetium Tc 99m Sestamibi injection. Covidien’s generic product is fully substitutable for Cardiolite, the company said.
July 8, 2009 - Ziosoft Inc., a leader in advanced visualization and analysis software for medical imaging, has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its magnetic resonance (MR) cardiac function analysis application for use with the Ziostation thin-client system.
July 6, 2009 – Last week, Royal Philips Electronics released the Veradius X-ray system, a mobile C-arm with a super thin, flat detector.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 6, 2009 - ATS Medical Inc. today said the FDA cleared the first implant of the ATS Simulus Semirigid Annuloplasty Band, which was developed through the company’s collaboration with Genesee BioMedical and represents the latest addition to the expanding portfolio of valve repair products.
July 6, 2009 – Sanofi-aventis said last week the FDA approved its Multaq (dronedarone) 400 mg tablets for use in patients with atrial fibrillation (AF) or atrial flutter (AFL).
July 2, 2009 - The Centers for Medicare and Medicaid Services (CMS) today released its proposed 2010 Medicare physician fee schedule, which includes proposals to significantly cut payments for cardiovascular-related services, prompting a stern response from the American College of Cardiology (ACC). CMS projects the changes would reduce total Medicare payments to cardiology by 11 percent.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 2, 2009 – Researchers from Dartmouth-Hitchock Medical Center (DHMC) in Lebanon, N.H., have published a new study in the July issue of the Journal of Vascular Surgery (published by the Society for Vascular Surgery) about the trends in lower extremity endovascular interventions (angioplasty and atherectomy), lower extremity bypass surgery and major above and below the knee amputations in Medi
July 1, 2009 – Cardioxyl Pharmaceuticals Inc. announced today the initiation of a phase I/IIa dose-escalation study of lead drug candidate, CXL-1020, for the treatment of acute decompensated heart failure (ADHF).
July 1, 2009 – W. L. Gore & Associates said today it received FDA for a manufacturing change to the GORE VIABAHN Endoprosthesis, which is a result of the precision laser trimming technology that enables the removal of excess material at the device margin, resulting in a contoured edge.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 1, 2009 - Radiologists can effectively lower the patient radiation dose by approximately 44 percent and improve vascular enhancement without deterioration of image quality, while screening for possible pulmonary emboli using pulmonary CT angiography, according to a study Brigham and Women's Hospital and Harvard Medical School, Boston, Mass., published in the June issue of the American Journal
July 1, 2009 - Advanced visualization and analysis software company Ziosoft Inc. today announced that it has received CE marking approval for its Ziostation 3D thin-client software system.
July 1, 2009 - On Sept. 9, 2009, the American College of Radiology (ACR) will offer the inaugural Cardiac CT Certificate of Advanced Proficiency (CCT CoAP) Examination open to all physicians who meet the requisite eligibility requirements and professional experience qualifications.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
June 30, 2009 – Edwards Lifesciences Corp. said today new research demonstrates that using its minimally invasive PORT ACCESS System in mitral valve surgery significantly decreases the length of stay in hospitals and intensive care units (ICU), and improves other outcomes when compared to conventional sternotomy.
June 30, 2009 - Stentys this week said it secured the second tranche of its series B financing, which will enable the company to obtain CE marking and begin European marketing of the first self-expanding stent platform for the treatment of myocardial infarction.
June 30, 2009 – Physio-Control said yesterday its LUCAS 2 Chest Compression System was granted 510(k) market clearance by the FDA. Developed and manufactured by Jolife AB and distributed exclusively in the U.S. by Physio-Control, the LUCAS 2 is an automated, battery-powered device designed to give consistent, uninterrupted compressions to victims in cardiac arrest.